Mirum Pharmaceuticals Inc...

NASDAQ: MIRM · Real-Time Price · USD
74.65
0.45 (0.61%)
At close: Aug 27, 2025, 3:59 PM
70.32
-5.80%
After-hours: Aug 27, 2025, 07:58 PM EDT

Mirum Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-58.56M -77.34M -87.94M -97.3M -106.65M -156.05M -160.91M -164.19M -176.31M -129.19M -135.66M -41.69M -53.09M -70.06M -83.99M -178.74M -153.13M -132.49M
Depreciation & Amortization
24.22M 24.02M 23.63M 22.97M 19.58M 14.92M 10.73M 6.66M 5.21M 4.72M 3.68M 2.79M 1.76M 1.23M 975K 703K 680K 652K
Stock-Based Compensation
59.43M 52.8M 48.44M 44.91M 41.39M 37.91M 35.02M 32.2M 30.55M 29.01M 27.01M 25.68M 26.36M 24.36M 23.09M 21.1M 17.11M 15.27M
Other Working Capital
-17.68M -20.07M -15.88M -17.01M -2.26M -4.42M 12.58M 11.76M 11.24M 14.2M -4.51M -5.19M -4.42M -6.3M -5.67M -4.32M -3.34M -3.31M
Other Non-Cash Items
-4.99M 16.87M 15.64M 57.13M 48.06M 94.75M 97.76M 64.65M 67.61M 19.27M 19.05M -94.66M -92.55M -90.06M -90.41M 14.81M 9.18M 4.45M
Deferred Income Tax
n/a n/a n/a -30.31M -30.95M -30.92M -30.92M -7.19M -6.55M -13.16M -13.16M -5.49M -6.9M 923K 595K -1.11M 305K -939K
Change in Working Capital
-11.1M -23.19M 9.84M 655K 4.43M 16.72M -22.64M -20.73M -16.91M -24.89M -21.05M -5.64M -2.77M -13.61M 16.98M 7.34M 6.71M 17.13M
Operating Cash Flow
8.99M -6.85M 10.32M -1.23M -23.43M -21.96M -70.94M -88.6M -96.4M -114.24M -120.14M -119.01M -127.19M -147.22M -132.76M -135.89M -119.14M -95.93M
Capital Expenditures
-10.37M -21.02M -20.99M -25.97M -15.79M -20.08M -20.11M -15.35M -15.37M -319K -278K -19.04M -19.04M -19.02M -19.02M -49K -77K -130K
Cash Acquisitions
n/a n/a n/a 239.82M 27.06M 42.06M n/a -239.82M 52.45M 13.47M 55.52M 36.52M -42.99M -19M -21M -42.78M -42.78M -42.78M
Purchase of Investments
-92.15M -122.55M -89.03M -77.54M -61.94M -4.88M -27.33M -27.33M -144.84M -154.77M -132.32M -151.3M -83.5M -114.65M -198.03M -201.63M -189.88M -157.94M
Sales Maturities Of Investments
62.39M 37.33M 19.89M 10.75M 33M 88.5M 153M 177M 185M 168.3M 140.3M 151.3M 160.8M 143.5M 157.6M 137.25M 108.86M 129.4M
Other Investing Acitivies
-10M -20M -20M -22M 18M 13M 55.06M 84.06M -25.45M 13.53M 7.98M 107.98M 185.27M 136.83M 102.33M 16.11M -542K 9.89M
Investing Cash Flow
-40.13M -106.25M -90.13M -92.77M -257.49M -149.23M -107.2M -78.44M 24.79M 13.21M 7.7M 88.97M 166.26M 117.83M 48.55M -64.42M -81.1M -28.67M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a -2.03M -3.7M -3.7M -3.7M -1.67M n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
9.2M 22.85M 17.7M 14.29M 15.2M 122.61M 119.92M 119.96M 116.57M 3.2M 5.42M 3.32M 2.29M 66.86M 65.82M 115.53M 115.01M 49.1M
Financial Cash Flow
24.25M 22.85M 17.7M 14.14M 217.4M 324.82M 336.6M 334.49M 213.43M 103.97M 109.09M 110.03M 24.31M 84.98M 73.47M 207.36M 209.11M 143.22M
Net Cash Flow
-4.64M -90.35M -63.15M -79.42M -63.73M 153.42M 158.32M 167.3M 141.96M 3.15M -3.34M 79.92M 63.33M 55.59M -10.75M 7.07M 8.9M 18.64M
Free Cash Flow
-1.37M -27.87M -10.67M -27.2M -39.22M -42.04M -91.05M -103.95M -111.77M -114.56M -120.41M -138.05M -146.23M -166.24M -151.78M -135.94M -119.22M -96.06M